|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Loss for the year | |||||
| Add items not affecting cash: | |||||
| Stock-based compensation-option | |||||
| Stock-based compensation-DSU | |||||
| Changes in non-cash working capital items: | |||||
| Accounts receivable | |||||
| Prepaid expenses | |||||
| Accounts payable and accrued liabilities | |||||
| Cash used in operating activities | |||||
| Financing Activities | |||||
| Issuance of common shares | |||||
| Share issuance costs | |||||
| Cash provided by financing activities | |||||
| Effect of foreign exchange on cash and cash equivalents | |||||
| Decrease in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
Loading...
